Guggenheim Maintains Buy on Eli Lilly, Lowers Price Target to $928

Benzinga · 04/14 13:45
Guggenheim analyst Seamus Fernandez maintains Eli Lilly (NYSE:LLY) with a Buy and lowers the price target from $973 to $928.